Author name: andrewshd

Ron Rocca to Become Chief Executive Officer SAN DIEGO, CA – May 11, 2023 – Mindera Health™, the developer of Mind.Px™, the first realization of precision medicine in psoriasis, has announced a change in its executive leadership team. The company has announced industry veteran Ron Rocca will succeed George Mahaffey as President and Chief Executive […]

Mindera Health™ Announces Coverage with Evidence Project with Highmark, Inc. to Advance Moderate-to-Severe Psoriasis Patient Care and Reduce Specialty Drug Spending Project will evaluate Mind.Px’s™ impact on physician “trial and error” prescribing behavior and overall net savings by prescribing the correct biologic class the first time SAN DIEGO, CA – April 11, 2023 – Mindera

HOUSTON, TX – MARCH 21, 2023 – Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced today that use of its Aortix™ percutaneous mechanical circulatory support (pMCS) device led to rapid decongestion in a pilot study of patients admitted to the hospital with acute decompensated heart

Mindera Health™ Appoints Linh H. Le as Chief Financial Officer and Chief Operating Officer Industry Veteran will assist in commercialization of Mind.PxTM to implement precision medicine for biologic treatment of moderate-to-severe psoriasis SAN DIEGO, CA – March 14, 2023 – Mindera Health, the developer of Mind.Px™, the first realization of precision medicine in psoriasis, has

OAKLAND, Calif., Mar. 13, 2023 Koya Medical, a healthcare company on a mission to transform venous and lymphatic care through innovative, people-centric solutions, today announced their selection for a poster presentation of the NILE Trial at the upcoming Academy of Managed Care Pharmacy (AMCP) conference being held March 21-24, 2023, in San Antonio, Texas. The

HOUSTON, TX – FEBRUARY 22, 2023 – Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced today successful treatment of the first patients in the A PRIORI (Aortix therapy for Perioperative ReductIon Of Renal Injury) pilot trial to evaluate the performance of its Aortix™ percutaneous mechanical

New Peer-Reviewed Clinical Study Demonstrates Thoraguard® Advantages Over Conventional Analog Systems Following Lung Surgery OMAHA, Ne., September 13, 2022—Centese, Inc. announces the results of a newly published peer-reviewed clinical study on its Thoraguard Intelligent Chest Tube Management System for use following lung surgery. The study published in the Journal of Thoracic Disease by the thoracic

Peer-reviewed clinical study shows Thoraguard® delivers effective, automated chest tube drainage following cardiac surgery Omaha, NE, July 26, 2022 — Centese, Inc. announces the first peer-reviewed clinical study on its Thoraguard® digital drainage system for cardiac surgery at Stanford University Medical Center, published in the Journal of Thoracic and Cardiovascular Surgery Open. Thoraguard is the

San Carlos, Calif. (December 19, 2022) – Empirical Spine, Inc., a medical device company creating a new class of spinal implant, recently completed the final step in the U.S. Food & Drug Administration (FDA) submission process for the LimiFlex™ Dynamic Sagittal Tether™ (DST). The Premarket Approval (PMA) submission included Module III, with data and analysis

[SAN DIEGO, CA – December 12, 2022]  Mindera Health has completed a $20.3 million Series A-3 financing, led by Mountain Group Partners, Rockmont Investments, and Scientific Health Development, to continue its aggressive growth strategy for the company’s groundbreaking precision medicine technology in the dermatology space.  The funds will be used to expand the commercialization of Mind.Px™,